Stock Analysis: Everbright Securities, Zhongtong Bus, iHealth Medical, and ST Meisheng

【Answer 1】 1. Company Highlights: A leading enterprise in bus manufacturing; has developed new products including pure-electric buses and fuel-cell buses. 2. Fundamental Analysis: Zhongtong Bus operates in the automobile manufacturing industry. Its financial condition is stable, with Q1 revenue rising year-on-year. However, the company has yet to achieve profitability. Its current valuation is negative! — Q1 revenue: RMB 863 million, up 30.93% year-on-year; net profit: -RMB 35.29 million, representing a narrowed loss compared to the prior period. 3. Technical Analysis: Significant capital inflow over the past five trading days. The stock is currently in a short-term strong uptrend—suitable for buying on dips; short selling is not recommended at present. Long-term outlook: As of now, four major institutional investors hold a combined total of 254 million shares, accounting for 42.83% of the tradable A-shares. Institutional ratings are predominantly “buy” or “add”, indicating moderate investment value in this sector. iHealth Medical 1. Company Highlights: Over 20 years of expertise in the medical device sector; R&D capabilities rank among the industry’s best. 2. Fundamental Analysis: iHealth Medical belongs to the medical device industry, where both its revenue and net profit rank top-tier nationally. Its financial health is excellent, with explosive growth in both revenue and net profit over the past three years—and this robust momentum continues. Moreover, its profitability stands out as industry-leading. Its current P/E ratio is 1.9, within the historical normal valuation range, and comparatively lower than peers. — Q1 revenue: RMB 21.737 billion, up 6,646.79% year-on-year; net profit: RMB 14.312 billion, up 37,527.35% year-on-year. 3. Technical Analysis: Significant capital inflow over the past five trading days. The stock is currently in a short-term downtrend—suitable for selling at higher levels; buying is not recommended at present. Long-term outlook: As of now, seven major institutional investors hold a combined total of 125 million shares, accounting for 27.43% of the tradable A-shares. Most institutions assess its long-term investment value as average. ST Meisheng 1. Company Highlights: One of China’s leading manufacturers of animation-themed apparel. 2. Fundamental Analysis: ST Meisheng operates in the culture & media industry.

(002699) Earnings surge, major players quietly accumulating shares,逆势涨停 (rising against the market to hit the daily limit-up), investors comment: 'Time to hop on board and feast!'

【Answer 2】 Today, 32 stocks hit the daily limit-up across both exchanges, while 9 hit the daily limit-down. Sector performance: The Smart Government Affairs sector saw Tianxia Smart continue its consecutive limit-ups; the liquor sector continued declining, though Kweichow Moutai’s drop was relatively modest. The Two-Child Policy theme remained strong, with Starlight Entertainment, Bangbao Yizhi, Kedi Dairy, and Meisheng Culture all hitting the daily limit-up. Among individual stocks, Chengmai Technology upheld its leadership role, achieving a 7+1 consecutive limit-up streak and successfully executing a reversal pattern. Today we’ll analyze stock (002699): Meisheng Culture (002699) 1. Key Themes: Culture & Media, Virtual Reality, Two-Child Policy, Digital Currency, Online Games, Mobile Games. 2. Earnings Performance: According to Meisheng Culture’s annual report, revenue reached RMB 517 million, up 35.49% year-on-year—more than quadrupling from last quarter’s RMB 129 million. This growth stems primarily from the acquisition of NEW TIME, which expanded the company’s revenue consolidation scope, and from increased orders for IP-derived merchandise tied to the upcoming release of *Frozen II*. 3. Major Shareholder Holdings: Data shows that 49 institutions hold Meisheng Culture shares, collectively holding 470 million shares valued at RMB 2.82 billion—representing 63.98% of total tradable shares. This marks an increase of 7.0161 million shares versus the prior period. Let’s now examine its price chart. 4. Price Chart & Market Behavior As of Friday’s close, Meisheng Culture’s latest share price stood at RMB 7.73—placing it among low-priced stocks. Total volume traded that day reached 520,500 lots, with a transaction value of RMB 7.031 billion—indicating exceptionally high turnover. Its turnover rate remained elevated at 7.08%. Technically, the stock is trending upward, with short-term performance outpacing the broader market. Amid a generally weak market, Meisheng Culture rose against the tide to hit the daily limit-up—demonstrating clear dominance by bulls, strong volume-supported gains, and sustained active trading.

Earnings call transcript: Mosaic misses Q2 2026 estimates but stock rises

Aug 5, 2026

Mosaic missed Q2 2026 earnings estimates due to sulfur supply constraints affecting phosphate production, yet its stock rose on strong liquidity and tight fertilizer market conditions.

Investing.com

2026-05-10

ESCO Technologies (NYSE:ESE) Releases Earnings Results, Beats Estimates By $0.01 EPS

2026-05-11

DuPont de Nemours Stock: Science-Driven Materials Leader

2026-05-17

DuPont de Nemours Inc Stock: Q1 Earnings Beat and Portfolio Reshaping Move Spotlight

2026-05-22

DuPont de Nemours Stock Beats Q1 Earnings Expectations Amid Water-Tech Push

2026-07-14

DuPont to Webcast Second-Quarter Results on Aug. 4